Diabetes

News

Lilly researches cell therapies for type 1 diabetes with Sig...

Eli Lilly and Sigilon Therapeutics have announced a collaboration to develop therapies based around capsules of genetically-engineered stem cells to treat type 1 diabetes.

News

Novo cleared to add key data to Tresiba label

Novo Nordisk can add data showing Tresiba can reduce the risk of hypoglycaemia to its label, a development which should help its fight competition from cheaper alternati

News

England’s diabetes prevention success: patients shed weight ...

Three years after launching a forward-thinking diabetes prevention programme, NHS England yesterday hailed early signs of a very significant impact on those at-risk people taking part.

Views & Analysis

Please can I have more Sugr?

What happens when big pharma buys your digital health start-up?

News

Trulicity helps SGLT-2 patients lower blood sugar

New phase 3b trial results show Lilly’s Trulicity combined with an SGLT2 inhibitor failed to show any benefits above and beyond Trulicity’s blood glucose lowering.

News